The use of pancuronium bromide in patients receiving lithium carbonate.
D000769:Anesthesia, Inhalation; D001285:Atropine / Q000627:therapeutic use; D002254:Carbonates / Q000627:therapeutic use; D004357:Drug Synergism; D005260:Female; D006801:Humans; D008094:Lithium / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*; D001523:Mental Disorders / Q000188:drug therapy; D008875:Middle Aged; D009388:Neostigmine / Q000627:therapeutic use; D009469:Neuromuscular Junction / Q000187:drug effects; D010197:Pancuronium / Q000008:administration & dosage / Q000494:pharmacology*; D013997:Time Factors
D002254:Carbonates; D009388:Neostigmine; D001285:Atropine; D008094:Lithium; D010197:Pancuronium